BACKGROUND: Gastric infection with Helicobacter pylori is the major cause of chronic active gastritis and is associated with the pathogenesis of peptic ulcer and gastric carcinoma. Gastric mucosal damage involves both host and H pylori dependent factors, such as the presence of the cag pathogenicity island and allelic variations of the vacA and iceA genes. AIMS: To evaluate the association of these virulence factors with the development of gastric malignancies, a retrospective study was performed on archived tissue routinely obtained for diagnostic histopathology. METHODS: DNA was extracted from formalin fixed, paraffin wax embedded gastric tissue sections of 93 patients with chronic active gastritis (n = 39), adenocarcinoma (n = 28), or mucosa associated lymphoid tissue (MALT) lymphoma (n = 24). The extracted DNA was used to perform a polymerase chain reaction based, simultaneous analysis of the following: (1) cagA status, (2) allelic variation of the iceA genes (iceA1, iceA2), allelic variation of the signal peptide (s1a, s1b, s2) and the midregion (m1, m1a, m2) of the vacA gene. RESULTS: The iceA1 gene showed a 3.6 fold and the vacA s1a variant a 4.2 fold higher prevalence in gastric adenocarcinoma than in gastritis. The combined presence of both the vacA s1a and iceA1 genes had a 5.6 fold higher frequency in adenocarcinoma. The vacA m2 allele was the predominant subtype in MALT lymphoma and the combination of the vacA m2 subtypes with the vacA s1 and the iceA1 variants occurred in MALT lymphoma nearly five times more often than in chronic active gastritis. CONCLUSIONS: Certain H pylori subtype combinations possess a differentiating and predictive value for the development of gastric adenocarcinoma and MALT lymphoma.
BACKGROUND: Gastric infection with Helicobacter pylori is the major cause of chronic active gastritis and is associated with the pathogenesis of peptic ulcer and gastric carcinoma. Gastric mucosal damage involves both host and H pylori dependent factors, such as the presence of the cag pathogenicity island and allelic variations of the vacA and iceA genes. AIMS: To evaluate the association of these virulence factors with the development of gastric malignancies, a retrospective study was performed on archived tissue routinely obtained for diagnostic histopathology. METHODS: DNA was extracted from formalin fixed, paraffin wax embedded gastric tissue sections of 93 patients with chronic active gastritis (n = 39), adenocarcinoma (n = 28), or mucosa associated lymphoid tissue (MALT) lymphoma (n = 24). The extracted DNA was used to perform a polymerase chain reaction based, simultaneous analysis of the following: (1) cagA status, (2) allelic variation of the iceA genes (iceA1, iceA2), allelic variation of the signal peptide (s1a, s1b, s2) and the midregion (m1, m1a, m2) of the vacA gene. RESULTS: The iceA1 gene showed a 3.6 fold and the vacA s1a variant a 4.2 fold higher prevalence in gastric adenocarcinoma than in gastritis. The combined presence of both the vacA s1a and iceA1 genes had a 5.6 fold higher frequency in adenocarcinoma. The vacA m2 allele was the predominant subtype in MALT lymphoma and the combination of the vacA m2 subtypes with the vacA s1 and the iceA1 variants occurred in MALT lymphoma nearly five times more often than in chronic active gastritis. CONCLUSIONS: Certain H pylori subtype combinations possess a differentiating and predictive value for the development of gastric adenocarcinoma and MALT lymphoma.
Authors: S Miehlke; J Yu; M Schuppler; C Frings; C Kirsch; N Negraszus; A Morgner; M Stolte; G Ehninger; E Bayerdörffer Journal: Am J Gastroenterol Date: 2001-04 Impact factor: 10.864
Authors: S Miehlke; C Kirsch; K Agha-Amiri; T Günther; N Lehn; P Malfertheiner; M Stolte; G Ehninger; E Bayerdörffer Journal: Int J Cancer Date: 2000-08-01 Impact factor: 7.396
Authors: P C Konturek; S J Konturek; T Starzyska; K Marlicz; W Bielanski; P Pierzchalski; E Karczewska; A Hartwich; K Rembiasz; M Lawniczak; W Ziemniak; E C Hahn Journal: Aliment Pharmacol Ther Date: 2000-10 Impact factor: 8.171
Authors: C Figueiredo; W G Quint; R Sanna; E Sablon; J P Donahue; Q Xu; G G Miller; R M Peek; M J Blaser; L J van Doorn Journal: Gene Date: 2000-04-04 Impact factor: 3.688
Authors: Barbara G Schneider; Dun-Fa Peng; M Constanza Camargo; M Blanca Piazuelo; Liviu A Sicinschi; Robertino Mera; Judith Romero-Gallo; Alberto G Delgado; Luis E Bravo; Keith T Wilson; Richard M Peek; Pelayo Correa; Wael El-Rifai Journal: Int J Cancer Date: 2010-12-01 Impact factor: 7.396
Authors: Chi-Chao Chan; Defen Shen; Manabu Mochizuki; John A Gonzales; Hunter K L Yuen; Yan Guex-Crosier; Phuc Lehoang Journal: Trans Am Ophthalmol Soc Date: 2006
Authors: P Lehours; S Dupouy; B Bergey; A Ruskoné-Foumestraux; J C Delchier; R Rad; F Richy; J Tankovic; F Zerbib; F Mégraud; A Ménard Journal: Gut Date: 2004-07 Impact factor: 23.059